← All companies

XTXX

Adastra Holdings Ltd.

XTXXF Pharmaceutical Preparations EDGAR ↗

$0.01

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$392K

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.01 – $0.51

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Dec 6, 2023 6-K FORM 6-K Aug 18, 2023 6-K FORM 6-K May 31, 2023 20-F FORM 20-F May 17, 2023 6-K FORM 6-K May 4, 2023 6-K FORM 6-K May 4, 2023 6-K FORM 6-K Apr 14, 2023 6-K FORM 6-K Mar 20, 2023 6-K FORM 6-K Mar 6, 2023 6-K FORM 6-K Feb 23, 2023 6-K FORM 6-K Feb 16, 2023 6-K FORM 6-K Feb 15, 2023 6-K FORM 6-K Nov 30, 2022 6-K FORM 6-K Sep 1, 2022 6-K FORM 6-K Aug 29, 2022 6-K FORM 6-K May 31, 2022 6-K FORM 6-K May 23, 2022 20-F FORM 20-F May 17, 2022 6-K FORM 6-K May 6, 2022 6-K FORM 6-K May 3, 2022 6-K FORM 6-K Apr 12, 2022 6-K FORM 6-K Apr 4, 2022

Other filings

15-12G FORM 15-12G May 1, 2024 NT 20-F FORM NT 20-F Apr 26, 2023 D Item 06b Sep 6, 2022 NT 20-F FORM NT 20-F May 3, 2022 UPLOAD Mar 28, 2022 CORRESP Mar 18, 2022 20FR12G/A FORM 20FR12G/A Mar 18, 2022 UPLOAD Mar 16, 2022 CORRESP Mar 11, 2022 20FR12G/A FORM 20FR12G/A Mar 11, 2022 UPLOAD Mar 2, 2022 CORRESP Feb 18, 2022 20FR12G/A FORM 20FR12G/A Feb 18, 2022 UPLOAD Feb 7, 2022 20FR12G/A FORM 20-FR12G/A Jan 21, 2022 CORRESP Jan 20, 2022 UPLOAD Jan 6, 2022 UPLOAD Dec 7, 2021